The increasing demand for precise immunological research and therapeutic creation has spurred significant improvements in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently manufactured using diverse expression methods, including microbial hosts, mammalian cell cultures, and i